Drugs / N-acetyl cysteine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01109381 | May 2010 → Dec 2011 | Helicobacter pylori infectious disease | Synergy Pharmaceuticals Pte. Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-acetyl cysteine | “N-acetyl cysteine (NAC)” NCT01109381 ↗ |
| Known as | NAC | “GT08 is the combination of omeprazole 40mg daily, lauric acid 150-300mg daily, NAC 1.2 - 2g daily” NCT01109381 ↗ |